OPPOSITE: Outcome Prediction of Systemic Treatment in Esophagogastric Carcinoma

NCT03429816 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Gastric Neoplasm
Gastroesophageal Junction Adenocarcinoma
Esophageal Adenocarcinoma
Gastric Adenocarcinoma
Esophageal Neoplasms

Interventions

PROCEDURE: Biopsy

Sponsor

University Hospital Heidelberg

Collaborators

[object Object]
[object Object]